Davidson Kempner Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-80,200
Closed -$6.22M 178
2017
Q4
$6.22M Sell
80,200
-39,100
-33% -$3.03M 0.08% 115
2017
Q3
$7.31M Buy
119,300
+40,200
+51% +$2.46M 0.1% 115
2017
Q2
$3.64M Buy
+79,100
New +$3.64M 0.05% 125